Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib

摘要

We read the recently published article entitled‘The Blood Neutrophil-to-lymphocyte Ratio PredictsSurvival in Patients with Advanced HepatocellularCarcinoma Receiving Sorafenib’ by Zheng et al. (2013),with interest. In the mentioned article authors aimedto determine the prognostic significance of the bloodneutrophil-to-lymphocyte ratio (NLR) in patients withadvanced hepatocellular carcinoma (HCC) who receivedsorafenib monotherapy. At the end of the article, theauthors concluded that elevated NLR is associated withworse overall survival (OS) and time to progression (TTP)for the patients with advanced HCC receiving sorafenibmonotherapy. We would like to thank the authors for theircontribution.